| TCR Repertoire Diversity of Peripheral PD-1+ CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung CancerPeripheral TCR Repertoire as … J Han, J Duan, H Bai, Y Wang, R Wan, X Wang, S Chen, Y Tian, D Wang, ... Cancer immunology research 8 (1), 146-154, 2020 | 204 | 2020 |
| Multiregion sequencing reveals the genetic heterogeneity and evolutionary history of osteosarcoma and matched pulmonary metastases D Wang, X Niu, Z Wang, CL Song, Z Huang, KN Chen, J Duan, H Bai, ... Cancer research 79 (1), 7-20, 2019 | 119 | 2019 |
| Inferring the evolution and progression of small-cell lung cancer by single-cell sequencing of circulating tumor cells Z Su, Z Wang, X Ni, J Duan, Y Gao, M Zhuo, R Li, J Zhao, Q Ma, H Bai, ... Clinical Cancer Research 25 (16), 5049-5060, 2019 | 79 | 2019 |
| Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L) 1 Inhibitors Z Wang, J Duan, G Wang, J Zhao, J Xu, J Han, Z Zhao, J Zhao, B Zhu, ... Journal of Thoracic Oncology 15 (4), 556-567, 2020 | 72 | 2020 |
| Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancerα2δ1 Subunit … J Yu, S Wang, W Zhao, J Duan, Z Wang, H Chen, Y Tian, D Wang, J Zhao, ... Clinical Cancer Research 24 (9), 2148-2158, 2018 | 56 | 2018 |
| Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic ProfilingChemotherapeutic Efficacy Prediction by Serum Metabolomics Y Tian, Z Wang, X Liu, J Duan, G Feng, Y Yin, J Gu, Z Chen, S Gao, H Bai, ... Clinical Cancer Research 24 (9), 2100-2109, 2018 | 56 | 2018 |
| Comprehensive analysis of the discordance of EGFR mutation status between tumor tissues and matched circulating tumor dna in advanced non–small cell lung cancer R Wan, Z Wang, JJ Lee, S Wang, Q Li, F Tang, J Wang, Y Sun, H Bai, ... Journal of Thoracic Oncology 12 (9), 1376-1387, 2017 | 44 | 2017 |
| Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma X He, Y Du, Z Wang, X Wang, J Duan, R Wan, J Xu, P Zhang, D Wang, ... Journal for immunotherapy of cancer 8 (2), 2020 | 36 | 2020 |
| Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer L Cai, H Bai, J Duan, Z Wang, S Gao, D Wang, S Wang, J Jiang, J Han, ... Journal for immunotherapy of cancer 7 (1), 1-11, 2019 | 34 | 2019 |
| Genetic load and potential mutational meltdown in cancer cell populations Y Zhang, Y Li, T Li, X Shen, T Zhu, Y Tao, X Li, D Wang, Q Ma, Z Hu, J Liu, ... Molecular biology and evolution 36 (3), 541-552, 2019 | 23 | 2019 |
| Refined stratification based on baseline concomitant mutations and longitudinal circulating tumor DNA monitoring in advanced EGFR-mutant lung adenocarcinoma under gefitinib … J Duan, JC Xu, Z Wang, H Bai, Y Cheng, T An, H Gao, K Wang, Q Zhou, ... Journal of Thoracic Oncology 15 (12), 1857-1870, 2020 | 20 | 2020 |
| The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma X Bai, Z Liu, X Shao, D Wang, E Dong, Y Wang, CI Wu, Y Yuan, X Lu, C Li Plos one 14 (2), e0211581, 2019 | 20 | 2019 |
| Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer Z Wang, S Fu, J Zhao, W Zhao, Z Shen, D Wang, J Duan, H Bai, R Wan, ... Cancer letters 440, 180-188, 2019 | 17 | 2019 |
| siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells C Li, Z Liu, F Yang, W Liu, D Wang, E Dong, Y Wang, CI Wu, X Lu Oncotarget 6 (25), 21603, 2015 | 8 | 2015 |
| Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumors Y Du, Y Liu, D Wang, H Bai, Z Wang, X He, P Zhang, J Tian, J Wang Journal for immunotherapy of cancer 10 (2), 2022 | 7 | 2022 |
| Clone evolution and genomic alteration analysis of osteosarcoma and matched lung metastasis. D Wang, J Wang, X Niu, Z Huang, Z Wang, Q Zhang, J Duan, H Bai, ... Journal of Clinical Oncology 35 (15_suppl), 11032-11032, 2017 | 2 | 2017 |
| Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel a2d1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer J Yu, S Wang, W Zhao, J Duan, Z Wang, H Chen, Y Tian, JZ Di Wang, ... | | |
